+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection



Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection



Netherlands Journal of Medicine International Edition 43(1-2): 74-82




(PDF emailed within 1 workday: $29.90)

Accession: 032189192

Download citation: RISBibTeXText


Related references

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases. Netherlands Journal of Medicine 43(1-2): 74-82, 1993

Low-dose hepatitis B immunoglobulin given on demand in combination with lamivudine: A highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. Transplantation 77(8): 1203-1208, April 27, 2004

Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clinic Proceedings 64(4): 429-432, 1989

Failure of interferon to prevent recurrent hepatitis b infection in hepatic allograft. Hepatology 8(5): 1287, 1988

Hepatitis B virus immunoglobulin on demand to prevent infection recurrence among liver allograft recipients: report of three cases. Revista Medica de Chile 140(1): 78-83, 2012

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis. Annals of Transplantation 23: 789-801, 2018

Ambulatory long-term immunoprophylaxis with intramuscular anti-HBs immunoglobulin to prevent hepatitis B reinfection after orthotopic liver transplantation. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A996, 2000

Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation. Clinical Transplantation 17(3): 254-258, 2003

Long-term survival in living related donor renal allograft recipients with hepatitis B infection. Transplantation 58(1): 118-119, 1994

Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin. Transfusion (bethesda). 35(2): 103-107, 1995

Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B. Revista do Instituto de Medicina Tropical de Sao Paulo 43(6): 335-337, 2002

Combined short-term hepatitis B immunoglobulin and long-term lamivudine versus HBIG monotherapy as Hepatitis B virus prophylaxis in liver transplant recipients. Hepatology 28(4 PART 2): 389A, 1998

Differential dynamics of hepatic protein expressions with long-term cultivated hepatitis C virus infection. Journal of Microbiology, Immunology, and Infection 2019, 2019

Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major. American Journal of Gastroenterology 97(4): 982-987, 2002

Long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-versus-host disease following marrow transplantation Clinical outcome and effect on subsequent immune recovery. Blood 86(10 SUPPL 1): 459A, 1995